Provider
This morning BioIQ, a health-testing and biometric-screening technology company, released its at-home COVID-19, Flu A/Flu B, and 21 Test Respiratory Panel saliva test.
The news comes months after reports that the company had furloughed staff and couldn't secure additional funding for its-ingestible sensor business.
The long-awaited decision is the first regulatory authorization for Akili, and the first game-based therapeutic that the FDA has greenlit for any condition.
The system is able to continuously transmit glucose data every minute.
From virtual management programs to hybrid closed loop systems, diabetes management companies put the spotlight on improved blood glucose management and positive clinical outcomes.
New funding will develop key markets and launch the company’s US presence.
The funding will be used to radically overhaul Germany’s desk-based operating health systems.
VR researcher and advocate Dr. Robert Louis gives HIMSS Media insight on the current state of VR in healthcare, and how the virus has impacted his hospital's rollout of the technology.
The company also announced its plans to launch Lumify, a handheld ultrasound device, in Japan.
Flare Capital Partners reviews the current landscape of substance use disorder treatment and highlights some early-stage tech companies tackling the ongoing opioid epidemic.